Acute Dapagliflozin Administration Ameliorates Cardiac Surgery-Associated Acute Kidney Injury in a Rabbit Model

CONCLUSIONS: Acute intravenous administration of dapagliflozin protects against CPB-induced AKI. Dapagliflozin may have direct renoprotective effects in renal tubular cells.PMID:38658352 | DOI:10.1253/circj.CJ-23-0864
Source: Circulation Journal - Category: Cardiology Authors: Source Type: research